Hillsdale Investment Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.08M | Buy |
63,000
+10,600
| +20% | +$1.36M | 0.3% | 49 |
|
|
2025
Q1 | $4.64M | Buy |
52,400
+1,570
| +3% | +$139K | 0.24% | 78 |
|
|
2024
Q4 | $4.43M | Buy |
50,830
+310
| +0.6% | +$27K | 0.22% | 106 |
|
|
2024
Q3 | $4.67M | Buy |
50,520
+250
| +0.5% | +$23.1K | 0.36% | 77 |
|
|
2024
Q2 | $5.42M | Sell |
50,270
-3,200
| -6% | -$345K | 0.43% | 52 |
|
|
2024
Q1 | $5.07M | Buy |
+53,470
| New | +$5.07M | 0.4% | 69 |
|
|
2021
Q2 | – | Sell |
-9,000
| Closed | -$875K | – | 578 |
|
|
2021
Q1 | $875K | Buy |
+9,000
| New | +$875K | 0.07% | 267 |
|